2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride
C14H18ClN5O — CID 175868336
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride
2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride (PubChem CID 175868336) has the molecular formula C14H18ClN5O and a molecular weight of 310.80 g/mol. Its IUPAC name is 2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride.
Molecular Properties
| Compound Name | 2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride |
|---|---|
| PubChem CID | 175868336 |
| Molecular Formula | C14H18ClN5O |
| Molecular Weight | 310.80 g/mol |
| Exact Mass | 310.14 |
| IUPAC Name | 2-(furan-2-ylmethyl)-6-[2-(trideuteriomethylamino)ethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;hydrochloride |
| SMILES | Cl.[2H]C([2H])([2H])NCCc1cc2c(N)nc(Cc3ccco3)nc2[nH]1 |
| InChI | InChI=1S/C14H17N5O.ClH/c1-16-5-4-9-7-11-13(15)18-12(19-14(11)17-9)8-10-3-2-6-20-10;/h2-3,6-7,16H,4-5,8H2,1H3,(H3,15,17,18,19);1H/i1D3; |
| InChIKey | RJHMDIYCUSHTSI-NIIDSAIPSA-N |
| XLogP | 1.91 |
| TPSA | 92.76 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 310.80 |
| LogP ≤ 5 | 1.91 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175868336 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.